Table of Contents

1 Lubiprostone Market Overview

• 1.1 Product Overview and Scope of Lubiprostone
• 1.2 Classification of Lubiprostone by Types
  • 1.2.1 Global Lubiprostone Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Lubiprostone Revenue Market Share by Types in 2018
  • 1.2.3 8 mcg Capsules
  • 1.2.4 24 mcg Capsules
• 1.3 Global Lubiprostone Market by Application
  • 1.3.1 Global Lubiprostone Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 CIC and OIC
  • 1.3.3 IBS-C
• 1.4 Global Lubiprostone Market by Regions
  • 1.4.1 Global Lubiprostone Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Lubiprostone Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Lubiprostone Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lubiprostone Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Lubiprostone Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lubiprostone Status and Prospect (2014-2024)
• 1.5 Global Market Size of Lubiprostone (2014-2024)

2 Manufacturers Profiles

• 2.1 Takeda Pharmaceuticals
  • 2.1.1 Business Overview
  • 2.1.2 Lubiprostone Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Takeda Pharmaceuticals Lubiprostone Revenue, Gross Margin and Market Share (2017-2018)

3 Global Lubiprostone Market Competition, by Players

• 3.1 Global Lubiprostone Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Lubiprostone Players Market Share
  • 3.2.2 Top 10 Lubiprostone Players Market Share
• 3.3 Market Competition Trend

4 Global Lubiprostone Market Size by Regions

• 4.1 Global Lubiprostone Revenue and Market Share by Regions
• 4.2 North America Lubiprostone Revenue and Growth Rate (2014-2019)
• 4.3 Europe Lubiprostone Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Lubiprostone Revenue and Growth Rate (2014-2019)
• 4.5 South America Lubiprostone Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Lubiprostone Revenue and Growth Rate (2014-2019)

5 North America Lubiprostone Revenue by Countries

• 5.1 North America Lubiprostone Revenue by Countries (2014-2019)
• 5.2 USA Lubiprostone Revenue and Growth Rate (2014-2019)
• 5.3 Canada Lubiprostone Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Lubiprostone Revenue and Growth Rate (2014-2019)

6 Europe Lubiprostone Revenue by Countries

• 6.1 Europe Lubiprostone Revenue by Countries (2014-2019)
• 6.2 Germany Lubiprostone Revenue and Growth Rate (2014-2019)
• 6.3 UK Lubiprostone Revenue and Growth Rate (2014-2019)
• 6.4 France Lubiprostone Revenue and Growth Rate (2014-2019)
• 6.5 Russia Lubiprostone Revenue and Growth Rate (2014-2019)
• 6.6 Italy Lubiprostone Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Lubiprostone Revenue by Countries

• 7.1 Asia-Pacific Lubiprostone Revenue by Countries (2014-2019)
• 7.2 China Lubiprostone Revenue and Growth Rate (2014-2019)
• 7.3 Japan Lubiprostone Revenue and Growth Rate (2014-2019)
• 7.4 Korea Lubiprostone Revenue and Growth Rate (2014-2019)
• 7.5 India Lubiprostone Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Lubiprostone Revenue and Growth Rate (2014-2019)

8 South America Lubiprostone Revenue by Countries

• 8.1 South America Lubiprostone Revenue by Countries (2014-2019)
• 8.2 Brazil Lubiprostone Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Lubiprostone Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Lubiprostone Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Lubiprostone by Countries

• 9.1 Middle East and Africa Lubiprostone Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Lubiprostone Revenue and Growth Rate (2014-2019)
• 9.3 UAE Lubiprostone Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Lubiprostone Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Lubiprostone Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Lubiprostone Revenue and Growth Rate (2014-2019)

10 Global Lubiprostone Market Segment by Type

• 10.1 Global Lubiprostone Revenue and Market Share by Type (2014-2019)
• 10.2 Global Lubiprostone Market Forecast by Type (2019-2024)
• 10.3 8 mcg Capsules Revenue Growth Rate (2014-2024)
• 10.4 24 mcg Capsules Revenue Growth Rate (2014-2024)

11 Global Lubiprostone Market Segment by Application

• 11.1 Global Lubiprostone Revenue Market Share by Application (2014-2019)
• 11.2 Lubiprostone Market Forecast by Application (2019-2024)
• 11.3 CIC and OIC Revenue Growth (2014-2019)
• 11.4 IBS-C Revenue Growth (2014-2019)

12 Global Lubiprostone Market Size Forecast (2019-2024)

• 12.1 Global Lubiprostone Market Size Forecast (2019-2024)
• 12.2 Global Lubiprostone Market Forecast by Regions (2019-2024)
• 12.3 North America Lubiprostone Revenue Market Forecast (2019-2024)
• 12.4 Europe Lubiprostone Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Lubiprostone Revenue Market Forecast (2019-2024)
• 12.6 South America Lubiprostone Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Lubiprostone Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology

Lubiprostone (rINN, marketed under the trade name Amitiza among others) is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation.

Scope of the Report:
The global Lubiprostone market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lubiprostone.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Lubiprostone market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lubiprostone market by product type and applications/end industries.

Market Segment by Companies, this report covers
Takeda Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
8 mcg Capsules
24 mcg Capsules

Market Segment by Applications, can be divided into
CIC and OIC
IBS-C